This module is for medical practitioners who wish to learn the developments in CDK 4/6 inhibitors for breast cancer patients.
By the end of this module, you should be able to:
- Focus on CDK4 and 6 as key regulators of the G1- S transition of the cell cycle.
- Acknowledge that an array of substrates for CDK4 and 6 have been identified, including the retinoblastoma protein, RB1, which can potentially lead to drug target discovery.
Requisitos del sistema
This module requires the learner to have a good, stable internet connection and runs best on INTERNET EXPLORER 7 AND ABOVE, and MOZILLA FIREFOX on either Windows or MacOS. FLASH ADD ON is also required to run this module.
If you are viewing this module on an iPad (through a browser), please download the free Articulate Mobile Player beforehand. Other tablet devices may not be compatible - please check for Flash compatibility.
If you are experiencing technical difficulties, please contact email@example.com and we will get back to you as soon as possible.
Política de divulgación
ecancer and everyone involved in the development of this module has no actual or potential conflict of interest whatsoever which impinges on the making, peer reviewing and dissemination of this e-learning module which was made possible through an unrestricted educational grant from Pfizer.
Production of this module was funded by an unrestricted grant from Pfizer.